• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation.心房颤动的口服抗凝和抗心律失常药物治疗
J Innov Card Rhythm Manag. 2018 Dec 15;9(12):3446-3452. doi: 10.19102/icrm.2018.091201. eCollection 2018 Dec.
2
Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi.在不进行长期抗凝治疗的情况下，通过经食管超声心动图排除心房血栓的存在后，进行房颤转复。
N Engl J Med. 1993 Mar 18;328(11):750-5. doi: 10.1056/NEJM199303183281102.
3
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.房颤的抗心律失常药物治疗与心脏死亡率。房颤卒中预防研究组。
J Am Coll Cardiol. 1992 Sep;20(3):527-32. doi: 10.1016/0735-1097(92)90003-6.
4
Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.抗心律失常药物所致心房扑动患者接受杂交治疗后房颤复发的危险因素。
Eur Heart J. 2003 Jul;24(13):1264-72. doi: 10.1016/s0195-668x(03)00233-1.
5
[Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation].[药物预防阵发性和慢性心房颤动复发]
Z Kardiol. 1994;83 Suppl 5:87-96.
6
[Relationship between efficacy of antiarrhythmic drug therapy and structural remodeling in patients with paroxysmal atrial fibrillation].[阵发性心房颤动患者抗心律失常药物治疗疗效与结构重塑的关系]
J Cardiol. 2005 Dec;46(6):229-36.
7
Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation.
Arch Intern Med. 1996;156(22):2585-92. doi: 10.1001/archinte.156.22.2585.
8
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.“真实世界”的心房颤动抗栓治疗：EORP-AF 初步调查。
Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.
9
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.冷冻消融或药物治疗后心房颤动的进展。
N Engl J Med. 2023 Jan 12;388(2):105-116. doi: 10.1056/NEJMoa2212540. Epub 2022 Nov 7.
10
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.氯吡格雷联合阿司匹林与口服抗凝药用于房颤患者预防血管事件的氯吡格雷与厄贝沙坦试验（ACTIVE W）：一项随机对照试验
Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4.

引用本文的文献

1
Computer Simulation of Catheter Cryoablation for Pulmonary Vein Isolation.用于肺静脉隔离的导管冷冻消融术的计算机模拟
Healthcare (Basel). 2024 Jul 30;12(15):1508. doi: 10.3390/healthcare12151508.
2
Letter from the Editor in Chief.主编来信。
J Innov Card Rhythm Manag. 2018 Dec 15;9(12):A7. doi: 10.19102/icrm.2018.091202. eCollection 2018 Dec.

本文引用的文献

1
Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation.心房颤动消融术患者围手术期口服抗凝治疗的应用
J Innov Card Rhythm Manag. 2018 Aug 15;9(8):3274-3281. doi: 10.19102/icrm.2018.090801. eCollection 2018 Aug.
2
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
3
Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events.阵发性心房颤动向持续性心房颤动进展与不良事件增加相关。
Stroke. 2018 Oct;49(10):2301-2308. doi: 10.1161/STROKEAHA.118.021396.
4
Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation: Understanding the Gaps in Evidence.非维生素 K 拮抗剂口服抗凝剂治疗的房颤患者行导管消融术时的术中抗凝管理：了解证据中的空白。
Circulation. 2018 Aug 7;138(6):627-633. doi: 10.1161/CIRCULATIONAHA.117.033326.
5
A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS.一项房室结消融联合心脏再同步治疗永久性心房颤动伴窄 QRS 波患者的随机对照研究。
Eur Heart J. 2018 Dec 1;39(45):3999-4008. doi: 10.1093/eurheartj/ehy555.
6
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.抗栓治疗心房颤动：CHEST 指南和专家报告。
Chest. 2018 Nov;154(5):1121-1201. doi: 10.1016/j.chest.2018.07.040. Epub 2018 Aug 22.
7
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.雷米雷司在植入式心脏复律除颤器高危患者中的应用：RAID 试验。
J Am Coll Cardiol. 2018 Aug 7;72(6):636-645. doi: 10.1016/j.jacc.2018.04.086.
8
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm.依替巴肽鼻喷剂快速转复室上性心动过速为窦性心律。
J Am Coll Cardiol. 2018 Jul 31;72(5):489-497. doi: 10.1016/j.jacc.2018.04.082.
9
Impact of Number of Oral Antiarrhythmic Drug Failures Before Referral on Outcomes Following Catheter Ablation of Ventricular Tachycardia.转诊前口服抗心律失常药物失败次数对导管消融治疗室性心动过速后结局的影响。
JACC Clin Electrophysiol. 2018 Jun;4(6):810-819. doi: 10.1016/j.jacep.2018.01.016. Epub 2018 Mar 28.
10
Andexxa--an antidote for apixaban and rivaroxaban.安多昔（Andexxa）——一种用于阿哌沙班和利伐沙班的解毒剂。
Med Lett Drugs Ther. 2018 Jun 18;60(1549):99-101.

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation.

作者信息

Reiffel James A

机构信息

Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University, New York, NY, USA.

出版信息

J Innov Card Rhythm Manag. 2018 Dec 15;9(12):3446-3452. doi: 10.19102/icrm.2018.091201. eCollection 2018 Dec.

DOI:10.19102/icrm.2018.091201
PMID:32494480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7252812/
Abstract
摘要